Search

Your search keyword '"MESH : Disease Progression"' showing total 43 results

Search Constraints

Start Over You searched for: Descriptor "MESH : Disease Progression" Remove constraint Descriptor: "MESH : Disease Progression"
43 results on '"MESH : Disease Progression"'

Search Results

1. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

2. A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

3. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis

4. Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

5. Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens

6. Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR

7. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort

8. First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort

9. Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohort

10. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort

11. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: The ANRS-EP38-IMMIP Study

12. [Muscularis mucosae invasion: prognostic factor for intravesical BCG immunotherapy failure for T1 bladder carcinoma]

13. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study

14. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course

15. DCC constrains tumour progression via its dependence receptor activity

16. Revisiting the canonical tumour progression model

17. Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial

18. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients

19. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort

20. Intrathecal synthesis of immunoglobulins in patients with unexplained intermediate uveitis

21. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells

22. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. : Lipid synthesis and cancer

23. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study

24. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort

25. Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection

26. A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells

27. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects

28. How do scoliotic women shrink throughout life?

29. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status

30. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression]

31. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study

32. [Targeted therapy for locally advanced and/or metastatic bladder cancer]

33. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling

34. Rurality and survival differences in lung cancer: a large population-based multivariate analysis

35. Exclusive chemoradiotherapy for patients with medically inoperable early-stage oesophageal cancer

36. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911

37. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix

38. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors

39. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions

40. Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study

41. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors

42. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. : The PROGRESS MRI Substudy

43. Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelines

Catalog

Books, media, physical & digital resources